3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
View Patent ↗The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a process for the manufacture of a compound of the formula II, or a salt thereof, and a compound of formula VI or a salt thereof, wherein R 3 and R 4 as well as Act are as defined in the specification, and processes of manufacturing these. Additionally transformation of compounds (VI) with metallo organic compounds (VII) give rise to the new compounds (VIII) which are direct precursors for the preparation of Aliskiren.
1. A compound of the formula (II)
wherein
R 3 is C 1-7 alkyl or C 3-8 cycloalkyl; and
R 4 is C 1-7 alkyl, C 2-7 alkenyl, C 3-8 cycloalkyl, phenyl- or naphthyl-C 1-4 alkyl each unsubstituted or mono-, di- or tri-substituted by C 1-4 alkyl,O—C 1-4 alkyl, OH, C 1-4 alkylamino, di-C 1-4 alkylamino, halogen and by trifluoromethyl;
or a salt thereof.
2. The compound according to claim 1 wherein R 3 and R 4 are independently branched C 3-6 alkyl.
3. The compound according to claim 1 having the following stereochemistry:
4. The compound according to claim 1 , having the formula
5. A compound of the formula (II′)
wherein
R 3 is C 1-7 alkyl or C 3-8 cycloalkyl; and
R 4 is C 1-7 alkyl, C 2-7 alkenyl, C 3-8 cycloalkyl, phenyl- or naphthyl-C 1-4 alkyl each unsubstituted or mono-, di- or tri-substituted by C 1-4 alkyl,O—C 1-4 alkyl, OH, C 1-4 alkylamino, di-C 1-4 alkylamino, halogen and by trifluoromethyl;
or a salt thereof.
6. The compound according to claim 5 wherein R 3 and R 4 are independently branched C 3-6 alkyl.
7. The compound according to claim 5 having the following stereochemistry:
8. The compound according to claim 5 , having the formula
9. A method for preparing a compound of formula (II) according to claim 1 , said method comprising subjecting a compound of formula (I′)
wherein R 3 and R 4 are as defined for a compound of formula (II) and Aux* is an auxiliary able to form an ester or amide with the carbonyl functionality, or a salt thereof, to hydrogenation to convert the azide moiety to an amine and to effect lactam ring closure.
10. A method for preparing a compound of formula (II) according to claim 1 , said method comprising subjecting a compound of formula (I)
wherein R 3 and R 4 are as defined for a compound of formula (II), or a salt thereof, to hydrogenation to convert the azide moiety to an amine and to effect lactam ring closure.
11. A method for preparing a compound of formula (II) according to claim 1 , said process comprising subjecting a compound of formula (III)
wherein R 3 and R 4 are as defined for a compound of formula (II), or a salt thereof, to conversion to an anhydride of formula (IV)
wherein R 3 and R 4 are as defined for a compound of formula (II) and R 6 is C 1-7 alkyl or C 3-8 cycloalkyl, or a salt thereof; to activate the acid moiety followed by hydrogenation to convert the azide moiety to an amine and to effect lactam ring closure.
12. A method for preparing a compound of formula (II) according to claim 1 , said process comprising subjecting a compound of formula (III)
wherein R 3 and R 4 are as defined for a compound of formula (II), or a salt thereof, to conversion to an ester of formula (V)
wherein R 3 and R 4 are as defined for a compound of formula (II) and R 7 is C 1-7 alkyl or C 3-8 cycloalkyl, or a salt thereof; followed by hydrogenation to convert the azide moiety to an amine and to effect lactam ring closure.
13. A method for preparing a compound of formula (VI)
wherein R 3 and R 4 are as defined for a compound of formula (II) and Act is an activating group selected from an amino protecting group, in particular a carbamate, or a salt thereof; comprising introducing the activating group at the nitrogen of a compound of formula (II) as given in claim 1 , or a salt thereof.
14. A compound of formula (VI)
wherein
R 3 is C 1-7 alkyl or C 3-8 cycloalkyl;
R 4 is C 1-7 alkyl, C 2-7 alkenyl, C 3-8 cycloalkyl, phenyl or naphthyl-C 1-4 alkyl each unsubstituted or mono-, di- or tri-substituted by C 1-4 alkyl,O—C 1-4 alkyl, OH, C 1-4 alkylamino, di-C 1-4 alkylamino, halogen and by trifluoromethyl; and
Act is an activating group selected from an amino protecting group, in particular a carbamate;
or a salt thereof.
15. The compound according to claim 14 , having the formula
16. The compound according to claim 14 , having the formula